ANUH PHARMA LTD. - 506260 - Submission Of Application For Re-Classification Of Status As Promoter/Public By The Listed Entity To The Stock Exchanges
Disclosure regarding submission of application for Reclassification of Promoters under Regulation 31A(8)(c) ANUH PHARMA LTD. - 506260 - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 7th November, 2022, inter alia: 1) To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th September, 2022; and 2) To consider any other matter with the permission of the Chairman. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Bharat Gangani, has tendered his resignation on 20th October, 2022 from the post of Company Secretary and Compliance Officer of the Company due to personal reasons. The Company has accepted his resignation and relive his with effect from the closing of business hours of Monday, 7th November, 2022. ANUH PHARMA LTD. - 506260 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Pursuant to the provisions of Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants), Regulations, 2018, please find attached herewith the copy of the certificate issued by M/s Bigshare Services Pvt. Ltd., the Registrar and Share Transfer Agent of the Company for the quarter ended 30th September, 2022. ANUH PHARMA LTD. - 506260 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bharat GanganiDesignation :- Company Secretary and Compliance Officer ANUH PHARMA LTD. - 506260 - Closure of Trading Window
Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company''s Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company will be closed for the Designated Persons and their immediate relatives, from Saturday, October 01, 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter/ half year ended September 30, 2022. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Investor Presentation
We are enclosing herewith our Company's Investor Presentation for Q1 FY2023. ANUH PHARMA LTD. - 506260 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copy of newspaper advertisement with respect to the Unaudited Financial Results for the quarter ended June 30, 2022, published in the Financial Express and Mumbai Lakshadeep on Saturday, August 06, 2022 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. ANUH PHARMA LTD. - 506260 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Anuh Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here ANUH PHARMA LTD. - 506260 - Consolidated Scrutinizer'S Report For Remote E-Voting And Voting During The AGM For The 62Nd Annual General Meeting Held On Friday, 5Th August, 2022.
Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we are enclosing herewith the Consolidated Scrutinizer's Report submitted by M/s Sanjay Doshi & Asso., Company Secretaries, Scrutinizer for the 62nd Annual General Meeting of the Company held on 5th August, 2022.